NDC product
MEDULTIMA ADVENTURE SUNSCREEN
NDC 84066-109 · Guangzhou Tata Biotechnology Co., Ltd.
Key facts
| Product NDC | 84066-109 |
|---|---|
| Proprietary name | MEDULTIMA ADVENTURE SUNSCREEN |
| Nonproprietary name | Homosalate, Octocrylene, Phenylbenzimidazole Sulfonic Acid, Ethylhexyl Salicylate, Butyl Methoxydibenzoylmethane |
| Substances | OCTOCRYLENE, ETHYLHEXYL SALICYLATE, PHENYLBENZIMIDAZOLE SULFONIC ACID, BUTYL METHOXYDIBENZOYLMETHANE, HOMOSALATE |
| Dosage form | CREAM |
| Route | TOPICAL |
| Labeler | Guangzhou Tata Biotechnology Co., Ltd. |
| Product type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Application number | M020 |
| Marketing start | Jun 4, 2026 |
| Listing certified through | Dec 31, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: